Dateien: | ||
URI: |
http://hdl.handle.net/10900/123462
http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-1234622 http://dx.doi.org/10.15496/publikation-64826 |
Dokumentart: | Dissertation |
Date: | 2022-01-21 |
Source: | Einhaus, J., Pecher, A., Asteriti, E., Schmid, H., Secker, KA., Duerr-Stoerzer, S., Keppeler, H., Klein, R., Schneidawind, C., Schneidawind, D., 2020. Inhibition of effector B cells by ibrutinib in systemic sclerosis. Arthritis Res Ther 22:66. https://doi.org/10.1186/s13075-020-02153-8 |
Language: | English |
Faculty: | 4 Medizinische Fakultät |
Department: | Medizin |
Advisor: | Schneidawind, Dominik (PD Dr.) |
Day of Oral Examination: | 2021-03-12 |
DDC Classifikation: | 610 - Medicine and health |
Other Keywords: |
![]() B-Zellen Ibrutinib ![]() Ibrutinib Systemic sclerosis |
License: | Publishing license excluding print on demand |
Show full item record |